关键词：PGD测试；遗传缺陷；胚胎鉴定；识别；单基因疾病
摘 要：PGD testing involves the identification of genetic defects in embryos. It is primarily performed to identify single-gene disorders such as sickle-cell anemia, cystic fibrosis, Huntington’s disease, hemophilia, Marfan’s disease, thalassemia, muscular distrophy, Tay-Sachs disease, and spinal muscular atrophy. PGD testing is generally carried out on people when they have a known genetic defect or in late-age pregnancy or if a woman has a history of repeated miscarriage. The transfer of an embryo into the uterus is done after PGD testing so that couples can make a decision about the consecutive steps they would like to take with regard to the IVF process. The technologies primarily used for PGD testing are PCR, FISH, CGH, and SNP. PCR is the most widely used technology in PGD. FISH testing is a technology that is beneficial in the determination of chromosomal abnormalities, X-linked diseases, and aneuploidy screening. CGH and SNP testing are advanced technologies in PGD that have a high accuracy in screening and diagnosis.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Technology

08. Geographical Segmentation

08.1 PGD Market in Americas

Market Size 08.1.1 and Forecast

08.2 PGD Market in EMEA Region

08.2.1 Market Size and Forecast

08.3 PGD Market in APAC Region

08.3.1 Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

16.1 Competitive Scenario

16.1.1 Key News

16.1.2 Mergers and Acquisitions

16.2 Vendor Analysis 2013

16.3 Other Prominent Vendors

17. Key Vendor Analysis

17.1 Genesis Genetics

17.1.1 Key Facts

17.1.2 Business Overview

17.1.3 Service Segmentation

17.1.4 SWOT Analysis

17.2 LabCorp

17.2.1 Key Facts

17.2.2 Business Overview

17.2.3 Business Segmentation

17.2.4 Business Segmentation by Revenue 2013

17.2.5 Business Segmentation by Revenue 2012 and 2013

17.2.6 Recent Developments:

17.2.7 SWOT Analysis

17.3 Reproductive Genetics Institute

17.3.1 Key Facts

17.3.2 Business Overview

17.3.3 Service Segmentation

17.3.4 SWOT Analysis

17.4 Reprogenetics

17.4.1 Key Facts

17.4.2 Business Overview

17.4.3 Service Segmentation

17.4.4 SWOT Analysis

18. Other Reports in this Series